Anavex Life Sciences
AVXL
#8658
Rank
HK$1.80 B
Marketcap
HK$19.44
Share price
-2.75%
Change (1 day)
-81.53%
Change (1 year)

Anavex Life Sciences (AVXL) - Cash on Hand

Cash on Hand as of December 2025 : HK$1.03 Billion

According to Anavex Life Sciences 's latest financial reports the company has HK$1.03 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Anavex Life Sciences - Cash on Hand chart (from 2005 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-09-30HK$0.79 B-22.32%
2024-09-30HK$1.02 B-13.11%
2023-09-30HK$1.18 B1.01%
2022-09-30HK$1.17 B-1.13%
2021-09-30HK$1.18 B422.48%
2020-09-30HK$0.22 B30.35%
2019-09-30HK$0.17 B-3.12%
2018-09-30HK$0.17 B-16.24%
2017-09-30HK$0.21 B200.76%
2016-09-30HK$71.25 M-39.87%
2015-09-30HK$0.11 B110.16%
2014-09-30HK$56.38 M2006.93%
2013-09-30HK$2.67 M2937.9%
2012-09-30HK$0.08 M-91.61%
2011-09-30HK$1.04 M-48.9%
2010-09-30HK$2.05 M-24.5%
2009-09-30HK$2.72 M5408.87%
2008-09-30HK$0.04 M25320.47%
2007-09-30HK$0 M-99.8%
2006-09-30HK$0.09 M1161.59%
2005-09-30HK$0 M-96.54%
2004-09-30HK$0.21 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Ligand Pharmaceuticals
LGND
HK$6.20 B 500.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
HK$2.65 B 156.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
HK$79.65 M-92.29%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
HK$1.86 B 80.95%๐Ÿ‡บ๐Ÿ‡ธ USA